Five-category and eighth-year return CRO Leadership Award Winner, Celerion, is asked by Clinical Leader expert contributor Krishnan Rajagopalan what the company attributes to their success and how such an honor impacts the company’s current relationships with sponsors. Hear from VP of early clinical research Philip Bach as he answers those questions and discusses what the company is planning to focus on in the future in order to speed up drug development and get more accurate reliable data. Celerion’s 2023 CRO Leadership Awards presented by Life Science Leader and Clinical Leader in partnership with DIA and with research conducted by Industry Standard Research include Capabilities, Compatibility, Expertise, Quality, and Reliability.